The Huazhong University of Science and Technology is a public research university located in Guanshan Subdistrict, Hongshan District, Wuhan, Hubei province, China. As a national key university directly affiliated to the Ministry of Education of China, HUST is a Project 985 and Class A Double First Class University.

During the past decade, Huazhong University of Science and Technology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Huazhong University of Science and Technology" #1 collaborator was "Centers for Disease Control and Prevention, China" with 1 trials as a collaborator, "Henan Cancer Hospital" with 1 trials as a collaborator, "Huazhong University of Science and Technology" with 1 trials as a collaborator, "Hunan Cancer Hospital" with 1 trials as a collaborator and "Qingdao University" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Huazhong University of Science and Technology" are "Cardiovascular Diseases" (2 trials), "Anal Fissure" (1 trials), "Anemia" (1 trials), "Breast Disease" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Huazhong University of Science and Technology" in a lesser frequency.

Most popular intervention types in "Huazhong University of Science and Technology" are "Dietary Supplement" (5 trials), "Drug" (3 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apatinib" (1 trials), "Apatinib+Capecitabine" (1 trials), "Diet and Lifestyle Intervention in Chinese Postpartum Women" (1 trials) and "Dietary and environmental exposure (Observational study)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Huazhong University of Science and Technology" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Huazhong University of Science and Technology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Huazhong University of Science and Technology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Huazhong University of Science and Technology, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".